Cognitive impairments in cardiological patients: diagnosis and prevention

The development of preventive measures to reduce the risk of developing cognitive decline is named by WHO among the main priorities of medicine. Cardiovascular diseases and cognitive disorders, on the one hand, have similar risk factors, such as obe-sity, smoking, dyslipidemia, lack of physical activity, low education level, and, on the other hand, the presence of atrial fibrillation (AF), arterial hypertension (AH), cardiac insufficiency (HF), chronic kidney disease, diabetes mellitus contributes to the progression of cognitive impairment. In the era of patient-oriented medicine, when choosing the optimal treatment regimen for AH, AF, and HF, it is necessary to take into account the potential of certain therapy regimens in the prevention of cognitive impair-ment. This article is devoted to a review of existing therapeutic strategies to prevent the development of cognitive deficits in patients with a cardiological profile. © 2022, Media Sphera Publishing Group. All rights reserved.

Авторы
Shavarova E.K. , Shavarov A.A. , Akhmetov R.E. , Kobalava Z.D.
Номер выпуска
6
Язык
Русский
Страницы
560-569
Статус
Опубликовано
Том
15
Год
2022
Организации
  • 1 Peoples Friendship University of Russia (RUDN University), Moscow, Russian Federation
  • 2 City Clinical Hospital named after V.V. Vinogradov, Moscow, Russian Federation
  • 3 LLC «Scientific and production company «PHARMASOFT», Moscow, Russian Federation
Ключевые слова
arterial hypertension; atrial fibrillation; cognitive impairment; dementia; heart failure; mexidol
Цитировать
Поделиться

Другие записи